Portal de Periódicos da CAPES

Development and External Validation of a Machine Learning Model for the Early Prediction of Doses of Harmful Intracranial Pressure in Patients with Severe Traumatic Brain Injury

2022; Mary Ann Liebert, Inc.; Volume: 40; Issue: 5-6 Linguagem: Inglês

10.1089/neu.2022.0251

1557-9042

Giorgia Carra, Fabián Güiza, Ian Piper, Giuseppe Citerio, Andrew I.R. Maas, Bart Depreitere, Geert Meyfroidt, Audny Anke, Ronny Beer, Bo‐Michael Bellander, Erta Beqiri, András Büki, Manuel Cabeleira, Marco Carbonara, Arturo Chieregato, Milano Bicocca, Hans Clusmann, Endre Czeiter, Marek Czosnyka, Ari Ercole, Shirin Frisvold, Raimund Helbok, Stefan Jankowski, Daniel Kondziella, Lars‐Owe Koskinen, Ana Kowark, David Menon, Kirsten Moeller, David Nelson, Anna Piippo-Karjalainen, Andreea Rădoi, Arminas Ragauskas, Rahul Raj, Jonathan R. Rhodes, Saulius Ročka, Rolf Rossaint, Juan Sahuquillo, Oliver Sakowitz, Peter Smielewski, Nino Stocchetti, Nina Sundström, Riikka TakalaTurku, Tomas Tamošuitis, Olli Tenovuo, Andreas Unterberg, Peter Vajkoczy, Alessia Vargiolu, Rimantas Vilcinis, Stefan Wolf, Alexander Younsi, Frederick A. Zeiler,

Acute Ischemic Stroke Management

Treatment and prevention of elevated intracranial pressure (ICP) is crucial in patients with severe traumatic brain injury (TBI). Elevated ICP is associated with secondary brain injury, and both intensity and duration of an episode of intracranial hypertension, often referred to as "ICP dose," are associated with worse outcomes. Prediction of such harmful episodes of ICP dose could allow for a more proactive and preventive management of TBI, with potential implications on patients' outcomes. The goal of this study was to develop and validate a machine-learning (ML) model to predict potentially harmful ICP doses in patients with severe TBI. The prediction target was defined based on previous studies and included a broad range of doses of elevated ICP that have been associated with poor long-term neurological outcomes. The ML models were used, with minute-by-minute ICP and mean arterial blood pressure signals as inputs. Harmful ICP episodes were predicted with a 30 min forewarning. Models were developed in a multi-center dataset of 290 adult patients with severe TBI and externally validated on 264 patients from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) dataset. The external validation of the prediction model on the CENTER-TBI dataset demonstrated good discrimination and calibration (area under the curve: 0.94, accuracy: 0.89, precision: 0.87, sensitivity: 0.78, specificity: 0.94, calibration-in-the-large: 0.03, calibration slope: 0.93). The proposed prediction model provides accurate and timely predictions of harmful doses of ICP on the development and external validation dataset. A future interventional study is needed to assess whether early intervention on the basis of ICP dose predictions will result in improved outcomes.